Post Marketing Information DHCPL 18/03/2024 Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine
ORAL Select a brand starting with the letter: P POLARINE SYRUP [SIN03182P] POLARINE TABLET [SIN07612P]